The AUA offers a portfolio of mentored research training awards to recruit outstanding young investigators into urologic research and foster their career success.
The Research Scholar Program, our premier funding opportunity, provides $40,000 per year for one- and two-year mentored training for:
Letters of intent are due by 5:00 p.m. EST on November 21, 2025. Full proposals are due by 5:00 p.m. EST on January 19, 2026.
1. Strong Urologic Relevance
The question must focus on a urology-specific disease or condition: prostate, bladder, kidney, urinary tract, male/female urogenital, reconstructive, pediatric urology, etc.
Whether basic science, translational, clinical, or health-services work — the link to urology must be explicit and central.
Predictor: Direct urology relevance — generic biomedical research without a urologic tie is rarely funded.
2. Scientific/Clinical Innovation + High Impact Potential
Projects that propose novel hypotheses, new diagnostics, new treatments, improved surgical techniques, better patient outcomes, or address unmet clinical needs tend to stand out.
Especially in oncology, benign disease complications, quality-of-life, and translational/therapeutic innovations.
Predictor: Innovation + potential to improve urologic care or generate new knowledge increases competitiveness.
3. Feasible, Well-Designed Study Plan and Realistic Aims
Given many grants are modest (pilot/seed or early-career), successful applications often have focused aims (1–3), achievable within 1–2 years, with clear and realistic deliverables.
For clinical or surgical research: clearly defined patient populations, inclusion/exclusion criteria, ethical protocols, surgical/therapy endpoints, and outcome measurements.
For lab-based or translational research: robust methodology, appropriate models, and feasibility.
Predictor: A realistic scope and well-structured plan outcompetes overly ambitious or vague proposals.
4. Investigator/Institutional Capacity & Support
For early-career applicants: mentorship, access to necessary clinical/lab facilities, protected time, and institutional backing.
For established investigators: prior track record, prior publications, existing infrastructure, and collaborator network.
Predictor: Strong institutional support and capable team make the proposal more credible.
5. Preliminary Data or Strong Justification (When Appropriate)
For translational or ambitious clinical/therapeutic proposals: having pilot data, retrospective analyses, or other preliminary evidence aids credibility.
For exploratory or novel concepts: a convincing, evidence-based rationale (from literature or well-designed rationale) is essential.
Predictor: Evidence of feasibility or strong rationale reduces perceived risk.
6. Clinical/Patient-Centered Relevance and Impact on Care
Projects with direct potential to improve patient outcomes, reduce morbidity, improve quality-of-life, optimize treatments, or refine surgical/therapeutic protocols are highly valued.
Studies that can influence clinical guidelines, standards of care, or surgical practice tend to receive stronger consideration.
Predictor: Patient-centered clinical relevance increases real-world value.
7. Clear Plan for Dissemination, Publication, & Future Funding Trajectory
For pilot/seed grants: proposals that are clearly positioned to yield data for larger external grants (NIH, multi-center trials, foundations) tend to be prioritized.
A dissemination plan — peer-reviewed publications, presentations at national/international urology meetings, etc. — demonstrates commitment to advancing the field.
Predictor: Clear path beyond the grant — toward broader impact — increases attractiveness.
8. Ethical, Regulatory & Practical Considerations Well Covered
For human studies / clinical trials / surgical interventions: clear ethical oversight, patient consent, risk management, safety monitoring.
For translational or lab-based: animal welfare, biosafety, reproducibility plans (power analysis, controls).
Realistic budget with clear justification — avoid over-budgeting or requesting unnecessary resources.
Predictor: Well-prepared regulatory, ethical and budget framework signals competence and lowers reviewer concern.
Proposals with weak or indirect connection to urology (broad biomedical research without urologic relevance).
Overly ambitious scope with many aims, unrealistic timelines, or resource demands mismatch funding level.
Lack of preliminary data or weak justification for high-risk proposals.
Poorly defined patient population, endpoints, or methodology (especially in surgical/clinical proposals).
Absence of institutional or collaborator support (especially for early-career proposals).
No clear plan for future funding, translation, or follow-up beyond the grant period.
Over-budgeting or poorly justified resource requests.
If you plan to submit to AUA:
Make sure your project is strongly rooted in urology — disease, surgery, physiology, patient care, or translational therapy.
Design a focused, feasible proposal with clearly defined aims, realistic timeline, and measurable outcomes.
Demonstrate institutional support and resources, especially if you are early-career.
Provide preliminary data if possible — or a coherent, literature-backed rationale if not.
Emphasize clinical or translational impact and patient benefit, not just academic interest.
Prepare a clear dissemination plan and outline how this grant will help you secure larger funding later.
Ensure ethical/regulatory preparedness, realistic budgeting, and feasibility in study design.
1. APPLICANT
To be eligible to compete for a 2026 Urology Care Foundation Research Scholar Award, applicants must be either a fellow or early career faculty for five (5) years or less by July 1, 2026.
In addition, applicants must be able to commit to at minimum one year of performance on the award project and at minimum 50 percent (MD or equivalent applicants) or 70 percent (PhD applicants) level of effort on their Research Scholar Award-funded research. Clinical fellows are permitted to request only one year of funding unless the applicant’s fellowship includes two years of appropriately protected time for research.
For the purpose of the RSA application, “level of effort” (50% (MD) or 70% (PhD)) refers to the researcher’s total time, not one’s protected time. If an individual has 2 days of protected time, this is only 40% of total time in reference to a standard 5 day working week and therefore would not qualify. At minimum, an MD or equivalent must have 2.5 days, and a PhD must have 3.5 days dedicated to the research project for the entire award period to qualify. Your level of effort does not have to reflect the percentage of salary the project is covering. Deviation from percent effort requirements will result in disqualification for award consideration or discontinuation of funding.
One proposal per applicant is allowed during a competition year. Former recipients of a Research Scholar Award may not apply for a subsequent Research Scholar Award. If the research is being conducted in the United States, applicants are not required to be U.S. citizens but must have valid Social Security numbers for Internal Revenue Service purposes.
Eligibility Exceptions Due to Extenuating Circumstances
Although the Research Scholar Award is intended to provide support during a pivotal period in the research career, the AUA also understands that extenuating circumstances, such as a leave of absence, may occur and impact eligibility for this award. Applicants seeking an exception to eligibility criteria related to time following first faculty position or degree completion should contact the AUAER Office of Research at grantsmanager@auanet.org prior to submitting a letter of intent.
Sponsor Institute/Organizations: American Urological Association
Sponsor Type: Corporate/Non-Profit
Address: 1000 Corporate Boulevard Linthicum, MD 21090 Phone: 410-689-3700 Toll-Free: 1-800-828-7866 Fax: 410-689-3912 Email: aua@AUAnet.org
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 19, 2026
Jan 19, 2026
$80,000
Affiliation: American Urological Association
Address: 1000 Corporate Boulevard Linthicum, MD 21090 Phone: 410-689-3700 Toll-Free: 1-800-828-7866 Fax: 410-689-3912 Email: aua@AUAnet.org
Website URL: https://www.auanet.org/research-and-data/research-awards/research-grant-opportunities/research-scholar-awards
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.